Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
NAV17.05.2024 | Diff.-1,4800 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
---|---|---|---|---|
198,8700CHF | -0,74% | thesaurierend | Aktien weltweit | Candriam ▶ |
GlobeNewswire
15:50
Kingsview Wealth Management Expands Servicing Relationship with Ultimus to Assist in Launch of Four ...
GlobeNewswire
12:55
YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
GlobeNewswire
20.05
Kayne Anderson Energy Infrastructure Fund Completes Private Placement of $75 Million of Notes